Trial intelligence / Profile preview

SKX-16 in Distal Subungual Onychomycosis

NCT05110638Phase 1Completed

Sponsor
Sato Pharmaceutical
Start
Sep 2021
Primary completion
May 2022
Modality
Small Molecules
Countries
1
01

Overview

Phase 1, open-label, single-arm trial of luliconazole vehicle cream in onychomycosis, sponsored by Sato Pharmaceutical. Primary endpoints: Area Under the Curve from Time Zero to 24 Hours, Area Under the Curve from Time Zero to Infinity at 36 days and 6 more. Started Sep 2021; status: completed.

02

Drugs

luliconazole vehicle cream
03

Conditions

onychomycosis

Beyond the preview

Go deeper on NCT05110638.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05110638.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call